Océane Landon‐Cardinal

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

Leandro Ladislau, Xavier Suárez‐Calvet, S. Toquet et al. · Brain · 2018 · 241 citations · Full text

Medicine, Dermatology, Pathology +17

Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy

Payam Mohassel, Océane Landon‐Cardinal, A. Reghan Foley et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 120 citations · Full text

Medicine, Molecular Genetics, Pathology +16

Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis

Akinori Uruha, Yves Allenbach, J.L. Charuel et al. · Neuropathology and Applied Neurobiology · 2018 · 77 citations · Full text

Medicine, Immunology, Pathology +17

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial

Olivier Benvéniste, Jean‐Yves Hogrel, Lisa Belin et al. · The Lancet Rheumatology · 2020 · 73 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

Alain Meyer, Yves Troyanov, Julie Drouin et al. · Arthritis Research & Therapy · 2020 · 69 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14